Mankind Pharma forays into the Agri-tech industry

New Delhi : Mankind Pharma has announced the launch of Mankind Agritech Pvt Ltd. The company has entered into the ever-growing Indian agri-Input segment to use technological innovations in the field and bring its expertise to Indian farmlands and the Indian agriculture consumers, respectively. The decision behind foraying into this division is to assist Indian farmers by providing new-age technologies and helping farmers for the betterment of the rural sector.

With the launch of Mankind Agritech, the company will be providing crop care solutions to Indian farmers, including weedicides, insecticides, fungicides, plant growth regulators and biologicals. Mankind Agritech will work towards food safety for the country . The company will invest in the new technological tools and aims to deliver the same to the farmers to support them.

Announcing the launch ,Mr Rajeev Juneja, Managing Director and Vice-Chairman, Mankind Pharma said, “We are happy to announce our launch in the Agritech domain with long-term investment plans with an initial 150 to 200 crore Capex infusion in the first two to three years. Mankind Agritech is committed to bring world-class crop protection technology to Indian farmers. Technology is playing a crucial role in ensuring the growth of the agriculture sector in India. Agritech has the potential to scale up the agricultural industry through technological intervention. If the farmers get the right products and tools they would be in a position to make an informed decision of using input and right technology. Mankind Agritech will ensure quality assurance to the farmers.

The new vertical will be headed by Mr Partha Sengupta, a veteran of the Indian agrochemical industry. Mr Partha Sengupta brings in a plethora of experience from the agrochemical industry with over three decades of experience in Sales and Marketing. Mr Sengupta was National Marketing Head and part of the Senior Leadership team at Dhanuka Agritech Limited overseeing Marketing operations in India, Bangladesh, and Nepal.

  • Related Posts

    • Pharma
    • April 19, 2024
    • 32 views
    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    Washington: The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called “boxed warning” to highlight the serious risk of T-cell blood…

    • Pharma
    • April 19, 2024
    • 23 views
    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Bengaluru: A startling revelation has come to light nearly 17,00 fake doctors have been identified in the AYUSH department in Karnataka. Shockingly, despite these discoveries, no significant action has been taken…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs